Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1130 of 5804
-
New transplant prep aims to boost survival in leukemia patients
Disease control Not yet recruitingSafety and Feasibility of a Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation in AML, MDS/AML and Higher Risk MDS
Phase: PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a simple supplement boost rectal cancer treatment?
Disease control Recruiting nowThis study is a prospective phase II clinical trial aimed at exploring the potential benefits of supplementing β-hydroxybutyrate with existing short course radiotherapy sequential immunotherapy and CAPEOX therapy.
Phase: PHASE2 • Sponsor: Tao Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a radiation boost help fight pancreatic cancer?
Disease control Not yet recruitingThe goal of this observational study is to learn about the efficacy and safety of the Volumetric Modulated Arc Therapy (VMAT) dose sculpting technique combined with different radiotherapy doses (local dose escalation vs. conventional dose) in patients with unresectable pancreatic…
Sponsor: Chifeng Tumor Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New PET scan could sharpen detection of neuroendocrine tumors
Diagnosis Not yet recruitingThe study aims to elucidate how 18F-Octreotide PET/CT or PET-MR can assist in accurate localization, treatment planning, prognostic predictions, and the selection of PRRT efficacy in neuroendocrine tumors. It also highlights important applications in lesion segmentation measureme…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Glowing dye guides surgeons to precise liver cancer removal
Disease control Recruiting nowThis prospective, single-arm exploratory study evaluates the feasibility and safety of a novel ICG-Cisplatin self-assembled nanoprobe (NIR-II NanoM) for fluorescence-guided surgery in patients with Hepatocellular Carcinoma (HCC). Participants will receive a transarterial injectio…
Phase: EARLY_PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Poop pills may reboot liver cancer therapy
Disease control Recruiting nowThe purpose of this study is to evaluate whether fecal microbiota transplantation (FMT), when administered in combination with atezolizumab and bevacizumab, can improve treatment response in participants with hepatocellular carcinoma (HCC) whose disease has progressed during prio…
Phase: PHASE2 • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a dose increase control lung cancer that Isn't shrinking?
Disease control Not yet recruitingThis study evaluates the efficacy and safety of Firmonertinib 160 mg once daily in patients with EGFR-mutant, advanced NSCLC who achieve stable disease after first-line Firmonertinib 80 mg for 8 weeks.
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Double procedure may keep AFib away longer
Disease control OngoingThe goal of this clinical trial is to learn whether adding renal denervation (RDN) to pulsed-field ablation (PFA) reduces recurrence of atrial tachyarrhythmias in adults (≥18 years) with persistent atrial fibrillation undergoing first-time ablation while off antiarrhythmic drugs.…
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a simple drug cocktail stop postpartum bleeding?
Prevention Not yet recruitingWhile Carbetocin is effective in reducing PPH, the combination of oxytocin, Tranexamic acid, and Ergot derivatives may offer additional benefits in high-risk populations. We hypothesize that the combination regimen will reduce PPH incidence and severity compared to Carbetocin alo…
Phase: NA • Sponsor: Cairo University • Aim: Prevention
Last updated Jun 27, 2026 08:08 UTC
-
Red light therapy tested to stop Kids' eyesight from worsening
Disease control Not yet recruitingThe goal of this clinical trial is to verify the effectiveness and safety of non-laser LED red light combined with defocus lens therapy for controlling myopia progression and evaluate the impact of different intervention durations in 6-14 years old children and adolescents with m…
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
VR hypnosis offers new hope for sleep in young cancer survivors
Symptom relief Not yet recruitingThe study aims to examine the effectiveness of virtual reality (VR) hypnosis for improving sleep in among Chinese childhood cancer survivors. Investigators will conduct a three-arm mixed-methods randomized controlled trial (RCT) among 186 Chinese Childhood Cancer Survivors (CCCs)…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Swallowing app aims to ease recovery after oral cancer surgery
Symptom relief Not yet recruitingThis study aims to examine the effects of a swallowing care program combined with an exercise mobile application (App) on swallowing function, anxiety, and quality of life in patients with oral cancer after flap reconstruction surgery. The goal is to determine whether integrating…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Virtual reality workouts could help older adults stay steady on their feet
Symptom relief Not yet recruitingThis study will compare two exercise-based rehabilitation programs to improve balance and reduce fall risk in adults aged 45 years and older who have had at least one fall in the past year or have balance problems. Participants will be assigned to one of two groups: (1) a virtual…
Phase: NA • Sponsor: Umm Al-Qura University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Steroid shot before aortic surgery may prevent dangerous inflammatory reaction
Prevention Not yet recruitingPostimplantation syndrome (PIS) is a common and clinically important complication following thoracic endovascular aortic repair (TEVAR). PIS is characterized by a strong systemic inflammatory response to the stent-graft implantation and is manifested by flu-like symptoms, which i…
Phase: NA • Sponsor: University of Belgrade • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Liver cirrhosis patients: new drug may cut rebleeding risk
Disease control ENROLLING_BY_INVITATIONCirrhosis is a serious liver disease where scar tissue replaces healthy liver tissue, often leading to portal hypertension-a condition where blood pressure in the liver's blood vessels rises. A life-threatening complication of this is variceal bleeding, which happens when swollen…
Phase: PHASE4 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New CAR-T therapy targets lymphoma that escapes standard treatment
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and tolerability of BAFF-R CAR-T Cells in Adult Subjects with CD19-Negative relapsed or refractory B-Cell Lymphoma.
Phase: PHASE1 • Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a Weight-Loss drug protect your muscles? new study investigates
Disease control Recruiting nowThis study is evaluating whether a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, tirzepatide, can affect the function, structure and metabolism of skeletal muscles in adults with obesity. Participants, premenopausal …
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Cannabis pills could replace opioids for back pain, major trial launches
Symptom relief Recruiting nowThe overall objectives of this study are to investigate the efficacy of extended cannabis treatment to reduce patient exposure to prescription opioids through its use 1) as a non-opioid analgesic treatment, and 2) as a therapy for reducing high-dose opioid use in patients with ch…
Phase: PHASE3 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New hope against drug-resistant lung bacteria? rifabutin trial begins
Disease control Recruiting nowBackground: Mycobacterium abscessus, one of the most common species of nontuberculous mycobacterium (NTM), poses a significant clinical challenge due to its natural resistance to antibiotics and high treatment failure rates, particularly in lung diseases. Among its subspecies, M.…
Phase: PHASE4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Text messages and chatbots may help catch lung cancer earlier in underserved communities
Disease control Recruiting nowThe long-term goal of this program of research is to increase the reach of Lung Cancer Screening (LCS) among low-resource healthcare settings and populations. The proposed project, LUNG-IS, is a mixed-methods, pre-post quasi-experimental design conducted in three Utah safety-net …
Phase: NA • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC